This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email email@example.com.
Please tell us what format you need. It will help us if you say what assistive technology you use.
This Medicines and Healthcare products Regulatory Agency (MHRA) guidance for the pharmaceutical industry selecting or constructing a product name covers:
the criteria used to assess the suitability of invented names
additional criteria used to assess the suitability of invented names for non-prescription medicines
criteria used in assessing the suitability of qualifiers/abbreviations
criteria used in assessing the acceptability of umbrella segments of product names
criteria for the generic naming of medicines, international non-proprietary names or common name